ImmunityBio (NasdaqGS:IBRX) completed enrollment early in its pivotal Phase 2 bladder cancer trial for ANKTIVA. Interim analysis showed a statistically significant improvement in complete response ...

DEAR DR. ROACH: About two weeks ago, I had a cystoscopy to check out my bladder. Three weeks prior to this, I had a scan to ...

Despite speculation about a possible connection between Iowa farmers’ exposure to chemicals and the state’s steep cancer rate ...

Here's why it is a major problem that needs attention and how you can do the purity check at home.

CG Oncology, Inc. (NASDAQ:CGON) is among the 10 Fastest Growing NASDAQ Stocks to Buy. On February 27, 2026, H.C. Wainwright ...

Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.

Deion Sanders' doctor reveals the Colorado coach nearly lost his leg following blood clot surgery during the 2025 season.

My doctor’s office makes patients sign in for appointments on their electronic kiosks. When you sign in, you must accept that ...

ImmunityBio has reached a significant milestone in a pivotal Phase 2 study for bladder cancer. The biopharmaceutical company has completed patient enrollment for its QUILT 2.005 trial ahead of ...

Dr Punam Krishnan discussed three common side effects of the jabs which she says patients should discuss with their doctor if they persist ...

Johnson & Johnson (NYSE:JNJ) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On March 2, BofA ...

GoodRx, a platform for medication savings, outlines 10 things not covered by Medicare—and a few ways to pay for them.